Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Leap Therapeutics Inc (LPTX) USD0.001

Sell:$1.11 Buy:$1.15 Change: $0.05 (4.17%)
NASDAQ:0.05%
Market closed |  Prices as at close on 13 November 2019 | Switch to live prices |
Sell:$1.11
Buy:$1.15
Change: $0.05 (4.17%)
Market closed |  Prices as at close on 13 November 2019 | Switch to live prices |
Sell:$1.11
Buy:$1.15
Change: $0.05 (4.17%)
Market closed |  Prices as at close on 13 November 2019 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Leap Therapeutics, Inc., formerly HealthCare Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company. The Company engages in acquiring and developing therapeutics in cancer biology. Its lead product candidates for use in clinical trials include TRX518 and DKN-01. DKN-01 is a monoclonal antibody targeting Dickkopf-related protein 1 (DKK1). TRX518 is a monoclonal antibody targeting the glucocorticoid-induced tumor necrosis factor-related receptor (GITR). DKN-01 has potential as a targeted cancer treatment in esophageal cancer, cholangiocarcinoma, non-small cell lung cancer, and other tumor types, such as pancreatic, gastric, liver, head and neck, uterine, and prostate cancers and multiple myeloma. It is conducting two clinical trials of TRX518 in patients with advanced solid tumors and have evidence of biomarker modulation and clinical activity. DKN-01 has been tested in a pilot study in patients with multiple myeloma in combination with lenalidomide and dexamethasone. .

Contact details

Address:
47 Thorndike St Ste B1-1
CAMBRIDGE
02141-1799
United States
Telephone:
+1 (617) 2524343
Website:
https://www.leaptx.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
LPTX
ISIN:
US52187K1016
Market cap:
$28.85 million
Shares in issue:
24.04 million
Sector:
Biotechnology
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel


Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.